Cardiac arrest remains a major health problem in the UnitedStates and other Western nations. Of the approximately 1000sudden deaths that occur each day in the United States, it isestimated that as many as 20 to 40 percent result from asystoliccardiac arrest.1,2,3 In this issue of the Journal, Wenzel etal.4 demonstrate the success of vasopressin alone and vasopressinfollowed by epinephrine in refractory asystolic cardiac arrest an important breakthrough in the science of resuscitation.These advances should be translated into a new standard of carewithout delay. Medical policymakers should do whatever is necessaryto . . . [Full Text of this Article]
Source Information
From the Departments of Medicine and Research, Brigham and Women's Hospital, Veterans Affairs Boston Health Care System, and Harvard Medical School all in Boston.
Heath, J., Hanson, D., Long, R., Crowell, N. A.
(2005). Critical Care Providers' Perceptions of the Use of Vasopressin in Cardiac Arrest. Am J Crit Care
14: 481-492
[Abstract][Full Text]
El-Menyar, A. A.
(2005). The Resuscitation Outcome: Revisit the Story of the Stony Heart. Chest
128: 2835-2846
[Abstract][Full Text]
Koshman, S. L, Zed, P. J, Abu-Laban, R. B
(2005). Vasopressin in Cardiac Arrest. The Annals of Pharmacotherapy
39: 1687-1692
[Abstract][Full Text]
Aung, K., Htay, T.
(2005). Vasopressin for Cardiac Arrest: A Systematic Review and Meta-analysis. Arch Intern Med
165: 17-24
[Abstract][Full Text]
Nolan, J. P., Nadkarni, V., Montgomery, W. H., Alvarez, G. F., Bihari, D., Ballew, K. A., Aberegg, S. K., Wenzel, V., Arntz, H. R., Lindner, K. H., Sharma, G.V.R.K., McIntyre, K. M.
(2004). Vasopressin versus Epinephrine for Cardiopulmonary Resuscitation. NEJM
350: 2206-2209
[Full Text]